Ultramicrosize Griseofulvin Tablets, USP are indicated for the treatment of the ringworm infections.

Ultramicrosize Griseofulvin Tablets, USP
  • Compare to
    GRIS-PEG®*
Inactive Ingredients

lactose monohydrate, corn starch, microcrystalline cellulose, povidone, polyethylene glycol 400, poloxamer 188, anhydrous lactose, silicon dioxide, crospovidone and magnesium stearate.

*GRIS-PEG® is a registered trademark of Valeant Pharmaceuticals International, Inc.

Ultramicrosize Griseofulvin Tablets, USP 125 mg

  • Package size
    30ct
  • Rating
    AB
  • Strength
    125 mg
  • NDC Code
    42794-0013-08
Ultramicrosize Griseofulvin Tablets, USP 125 mg

Ultramicrosize Griseofulvin Tablets, USP 250 mg

  • Package size
    30ct
  • Rating
    AB
  • Strength
    250 mg
  • NDC Code
    42794-0014-08
Ultramicrosize Griseofulvin Tablets, USP 250 mg

 

* Disclaimer: All images shown are for illustrative purposes only. Actual product may vary due to image enhancement. The images and information for a particular product may change over time. For the most up-to-date product information, please contact Sigmapharm Laboratories, LLC.